Correlation Between Hoth Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Hoth Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hoth Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hoth Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Hoth Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hoth Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hoth Therapeutics and Revelation Biosciences.
Diversification Opportunities for Hoth Therapeutics and Revelation Biosciences
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Hoth and Revelation is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Hoth Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Hoth Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hoth Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Hoth Therapeutics i.e., Hoth Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Hoth Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days Hoth Therapeutics is expected to generate 0.78 times more return on investment than Revelation Biosciences. However, Hoth Therapeutics is 1.29 times less risky than Revelation Biosciences. It trades about 0.01 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.02 per unit of risk. If you would invest 114.00 in Hoth Therapeutics on September 2, 2024 and sell it today you would lose (30.00) from holding Hoth Therapeutics or give up 26.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hoth Therapeutics vs. Revelation Biosciences
Performance |
| Timeline |
| Hoth Therapeutics |
| Revelation Biosciences |
Hoth Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hoth Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Hoth Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hoth Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Hoth Therapeutics vs. Avenue Therapeutics | Hoth Therapeutics vs. Revelation Biosciences | Hoth Therapeutics vs. Neurobo Pharmaceuticals | Hoth Therapeutics vs. Virax Biolabs Group |
| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |